A Prospective Cohort Study of IgG4RD in China

NCT01670695 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2017-04-11

No results posted yet for this study

Summary

This is an cohort study to investigate the disease course and treatment response of patients with IgG4-related disease.

Conditions

Sponsors & Collaborators

  • Peking Union Medical College Hospital

    lead OTHER

Principal Investigators

  • Wen Zhang, MD · Deptment of Rheumatology, Peking Union Medical College Hospital

  • Fengchun Zhang · Deptment of Rheumatology, Peking Union Medical College Hospital

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2032-01-31
Completion
2032-01-31

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01670695 on ClinicalTrials.gov